ATE323493T1 - Gesteuerte freisetzung von antidepressiva - Google Patents

Gesteuerte freisetzung von antidepressiva

Info

Publication number
ATE323493T1
ATE323493T1 AT99971322T AT99971322T ATE323493T1 AT E323493 T1 ATE323493 T1 AT E323493T1 AT 99971322 T AT99971322 T AT 99971322T AT 99971322 T AT99971322 T AT 99971322T AT E323493 T1 ATE323493 T1 AT E323493T1
Authority
AT
Austria
Prior art keywords
antidepressants
controlled release
triazolones
exemplified
methods
Prior art date
Application number
AT99971322T
Other languages
English (en)
Inventor
Evangeline G Cruz
Noymi Yam
Adam Zhong
Atul Ayer
Padmanabh Bhatt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE323493T1 publication Critical patent/ATE323493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99971322T 1998-11-02 1999-10-26 Gesteuerte freisetzung von antidepressiva ATE323493T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10675898P 1998-11-02 1998-11-02
US10667798P 1998-11-02 1998-11-02

Publications (1)

Publication Number Publication Date
ATE323493T1 true ATE323493T1 (de) 2006-05-15

Family

ID=26803899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971322T ATE323493T1 (de) 1998-11-02 1999-10-26 Gesteuerte freisetzung von antidepressiva

Country Status (12)

Country Link
EP (1) EP1126853B1 (de)
JP (1) JP4711510B2 (de)
KR (2) KR100734193B1 (de)
AT (1) ATE323493T1 (de)
AU (1) AU1230800A (de)
CA (1) CA2349719C (de)
CY (1) CY1105463T1 (de)
DE (1) DE69930952T2 (de)
DK (1) DK1126853T3 (de)
ES (1) ES2260962T3 (de)
PT (1) PT1126853E (de)
WO (1) WO2000025790A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ570198A (en) * 2002-07-29 2010-01-29 Alza Corp Methods and dosage forms for controlled delivery of paliperidone or risperidone
CA2494233A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
CN101703488B (zh) * 2008-12-16 2013-02-20 北京科信必成医药科技发展有限公司 具有润滑层结构的双层渗透泵控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
JP4015184B2 (ja) * 1993-08-31 2007-11-28 アルザ コーポレイション 疎水性剤を含有するディスペンサー
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
ES2208870T3 (es) * 1996-02-15 2004-06-16 Janssen Pharmaceutica N.V. Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina.
AU3290397A (en) * 1996-06-10 1998-01-07 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form

Also Published As

Publication number Publication date
JP4711510B2 (ja) 2011-06-29
CA2349719C (en) 2009-06-02
HK1038515A1 (en) 2002-03-22
EP1126853A1 (de) 2001-08-29
CY1105463T1 (el) 2010-04-28
EP1126853B1 (de) 2006-04-19
CA2349719A1 (en) 2000-05-11
KR20010075677A (ko) 2001-08-09
AU1230800A (en) 2000-05-22
ES2260962T3 (es) 2006-11-01
DE69930952T2 (de) 2006-08-31
KR100734193B1 (ko) 2007-07-02
PT1126853E (pt) 2006-07-31
DE69930952D1 (de) 2006-05-24
DK1126853T3 (da) 2006-08-14
WO2000025790A1 (en) 2000-05-11
KR20070040421A (ko) 2007-04-16
JP2002528505A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
TR199700092A2 (tr) Yeni, sübstitüe edilmis oksazolidinonlar.
FI913215A0 (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
ATE264863T1 (de) 28-epirapaloge
DZ2026A1 (fr) Compositions vaccinantes.
DZ2055A1 (fr) Compositions vaccinantes.
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
FR2694182B1 (fr) Attache pour prothèse, notamment interpédiculaire.
BR9703302A (pt) Aparelho e método para a geração e uso de ìons férricos
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
FR2684543B1 (fr) Ligament artificiel, notamment pour la cheville.
TR199901017A2 (xx) B�cek ilac� terkibi.
ATE323493T1 (de) Gesteuerte freisetzung von antidepressiva
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
ES2152315T3 (es) Xamoneline tartrato.
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
FI920080A0 (fi) Kulfaongare, som uppstannar kulor.
FI916018L (fi) 1,3-dioxolanderivat som kolesterol- saenkande medel.
FI915623L (fi) 2b,19-etylenbryggsteroider som aromatasinhibitorer.
TR199501276A2 (tr) Sübstitüe edilmis sikloalkilamino-ve-alkoksi-heterosaykillar, üretilmelerine mahsus usul ve zararlilarla mücadele maddesi olarak kullanilmalari.
DE60222552D1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1126853

Country of ref document: EP